Latest News

Press Release

May 12, 2022

BOYDSense selected in the Top 3 Diabetes Devices of the DCB Innovation Challenge 2022

[…]

Press Release

February 3, 2022

Ben Delhey appointed as CEO of BOYDSense, the MedTech subsidiary of Alpha MOS

[…]

Press Release

December 16, 2021

BOYDSense has been selected by the European Innovation Council (EIC) Accelerator

[…]

Press Release

June 15, 2021

Ben Delhey joins as Supervisory Board Member of BOYDSense, the MedTech subsidiary of Alpha MOS

[…]

Press Release

June 15, 2021

The University Hospital (CHU) of Toulouse will perform a clinical study for BOYDSense to enhance and validate its algorithm

[…]

Press Release

October 8, 2020

Sweet Ventures invests in BOYDSense to bring non-invasive glucose monitoring using breath analysis to people with diabetes

[…]

Press Release

October 28, 2019

BOYDSense diabetes device places among top innovations at 2019 RESI Innovation Challenge

San Bruno, Calif. – October 29, 2019 – Medical technology company BOYDSense, Inc. has returned from the RESI (Redefining Early Stage Investments) conference in Boston with a second-place finish in the RESI Innovation Challenge and myriad accolades […]

News

September 12, 2019

From 38 Finalists. RESI Boston’s Audience Selects Innovation Challenge Champions

Boston, Mass. - September 12, 2019 - The RESI Innovation Challenge showcased 38 emerging startups in the biotech, medtech, diagnostics and digital health fields. All the competitors brought novel, exciting discoveries to the technology showcase […]